CollPlant Biotechnologies Ltd (CLGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 6M 12M 18M FY21: 15.6M FY22: 299K FY23: 11M FY24: 515K FY25: 2.4M FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

-5M 0 5M 10M 15M FY21: 13.6M FY22: -101K FY23: 9M FY24: -1.1M FY25: 1.5M FY21 FY22 FY23 FY24 FY25

Operating Income Annual

-18M -12M -6M 0 6M 12M 18M FY21: 65K FY22: -17.1M FY23: -7.5M FY24: -17.3M FY25: -11.5M FY21 FY22 FY23 FY24 FY25

Net Income Annual

-18M -12M -6M 0 6M 12M 18M FY21: 237K FY22: -16.9M FY23: -7M FY24: -16.6M FY25: -11.5M FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 700K 1.4M 2.1M FY21: 2M FY22: 400K FY23: 2M FY24: 1.6M FY25: 835K FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-15M -10M -5M 0 5M 10M 15M FY21: 2.5M FY22: -13.7M FY23: -2.8M FY24: -14.1M FY25: -9.4M FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-18M -12M -6M 0 6M 12M 18M FY21: 1.1M FY22: -15M FY23: -3.7M FY24: -14.6M FY25: -9.4M FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 5M 10M 15M FY21: 12M FY22: 11M FY23: 11.4M FY24: 11.5M FY25: 12.2M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.